EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

3D printing and bioprinting in the battle against diabetes and its chronic complications

Indumathi Sathisaran

Frontiers in Bioengineering and Biotechnology · 28.05.2024 · 12

DOI: 10.3389/fbioe.2024.1363483 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 28.05.2024. Verfasst von Indumathi Sathisaran. Beteiligte Einrichtung: Department of Bioscience and Engineering, National Institute of Technology Calicut, Kozhikode, Kerala, India. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is a metabolic disorder characterized by high blood sugar. Uncontrolled blood glucose affects the circulatory system in an organism by intervening blood circulation. The high blood glucose can lead to macrovascular (large blood vessels) and microvascular (small blood vessels) complications. Due to this, the vital organs (notably brain, eyes, feet, heart, kidneys, lungs and nerves) get worsen in diabetic patients if not treated at the earliest. Therefore, acquiring treatment at an appropriate time is very important for managing diabetes and other complications that are caused due to diabetes. The root cause for the occurrence of various health complications in diabetic patients is the uncontrolled blood glucose levels. This review presents a consolidated account of the applications of various types of three-dimensional (3D) printing and bioprinting technologies in treating diabetes as well as the complications caused due to impaired blood glucose levels. Herein, the development of biosensors (for the diagnosis), oral drug formulations, transdermal drug carriers, orthotic insoles and scaffolds (for the treatment) are discussed. Next to this, the fabrication of 3D bioprinted organs and cell-seeded hydrogels (pancreas engineering for producing insulin and bone engineering for managing bone defects) are explained. As the final application, 3D bioprinting of diabetic disease models for high-throughput screening of ant-diabetic drugs are discussed. Lastly, the challenges and future perspective associated with the use of 3D printing and bioprinting technologies against diabetes and its related chronic complications have been put forward.

Schlagwörter

Stichwörter der Autor:innen

3D bioprinting3D printingcell-seeded hydrogelschronic complicationsdiabetesdiabetic disease modelsdiagnosistreatment

Autor:innen und Institutionen

  • Department of Bioscience and Engineering, National Institute of Technology Calicut, Kozhikode, Kerala, India.

Zitieren

APA

Sathisaran, I. (2024). 3D printing and bioprinting in the battle against diabetes and its chronic complications. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1363483

Vancouver

Sathisaran I. 3D printing and bioprinting in the battle against diabetes and its chronic complications. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1363483

BibTeX
@article{Sathisaran2024,
  author = {Sathisaran, Indumathi},
  title = {3D printing and bioprinting in the battle against diabetes and its chronic complications},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fbioe.2024.1363483}
}
Kostenlos starten →